Cite
HARVARD Citation
Kirchner, A. et al. (2022). Identification of a novel variant of FOXP3 resulting in severe immune dysregulation, polyendocrinopathy, enteropathy, X‐linked syndrome highlights potential pitfalls of molecular testing. Pediatric dermatology. 39 (3), pp. 483-485. [Online].